Medicare Enrolled

Dr. Anne Maynard, CNP

Nurse Practitioner - Primary Care · Glen Ellyn, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
430 PENNSYLVANIA AVE STE 300, Glen Ellyn, IL 60137
6304167766
In practice since 2009 (16 years)
NPI: 1336476985 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maynard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maynard? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maynard

Dr. Anne Maynard is a nurse practitioner - primary care in Glen Ellyn, IL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Maynard performed 3,341 Medicare services across 1,403 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maynard received a total of $6,755 from 27 pharmaceutical and/or device companies across 373 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - primary care. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maynard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 3% volume in IL $6,755 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,341
Medicare services
Top 3% in IL for nurse practitioner - primary care
1,403
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~209 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,680 $18 $27
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
452 $83 $229
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
298 $9 $50
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
201 $23 $91
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
135 $8 $20
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
83 $16 $86
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
54 $118 $307
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
53 $3 $12
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
52 $6 $30
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
52 $5 $27
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
46 $29 $152
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
43 $13 $69
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
42 $10 $55
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
42 $9 $46
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
29 $9 $62
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
22 $8 $44
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $56 $157
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
13 $32 $55
Parathyroid hormone level test
A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones.
12 $40 $212
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
12 $76 $103
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,755
Total received (2021-2024)
Avg $1,689/year across 4 years
Top 5% in IL for nurse practitioner - primary care
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
373
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,755 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,894
2023
$1,794
2022
$1,588
2021
$1,480

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$473
Lilly USA, LLC
$370
Xeris Pharmaceuticals, Inc.
$187
Novo Nordisk Inc
$152
Dexcom, Inc.
$114
SK Life Science, Inc.
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$94
Amgen Inc.
$76
Insulet Corporation
$74
SANOFI-AVENTIS U.S. LLC
$55
Amneal Pharmaceuticals LLC
$41
Amphastar Pharmaceuticals, Inc.
$37
BETA BIONICS, INC.
$32
TheracosBio, LLC
$31
Tandem Diabetes Care, Inc.
$29
GlaxoSmithKline, LLC.
$18
ABBVIE INC.
$14
Top 3 companies account for 54.4% of 2024 payments
All-time payments by company (2021-2024) ›
Lilly USA, LLC
$1,167
Novo Nordisk Inc
$957
Abbott Laboratories
$771
Dexcom, Inc.
$674
AstraZeneca Pharmaceuticals LP
$541
SANOFI-AVENTIS U.S. LLC
$444
Xeris Pharmaceuticals, Inc.
$416
Amgen Inc.
$354
Boehringer Ingelheim Pharmaceuticals, Inc.
$281
Tandem Diabetes Care, Inc.
$261
Insulet Corporation
$150
Medtronic, Inc.
$129
DEXCOM, INC.
$120
SK Life Science, Inc.
$97
Antares Pharma, Inc.
$53
Amneal Pharmaceuticals LLC
$41
Roche Diabetes Care, Inc.
$39
Amphastar Pharmaceuticals, Inc.
$37
ABBVIE INC.
$33
BETA BIONICS, INC.
$32
Neurocrine Biosciences, Inc.
$32
TheracosBio, LLC
$31
Ascensia Diabetes Care Us Inc.
$29
MannKind Corporation
$21
GlaxoSmithKline, LLC.
$18
Embecta Corp.
$16
AbbVie Inc.
$13
Top 3 companies account for 42.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Accu-Chek Guide Me · BAQSIMI · BD Nano 2nd Gen Pen Needle · Brenzavvy · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · InPen · JARDIANCE · LYUMJEV · MINIMED 770G · MINIMED 780G · MOUNJARO · NOCDURNA · Omnipod · Ozempic · Prolia · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SYNTHROID · Saxenda · TOUJEO · TRADJENTA · TRULICITY · TZIELD · UBRELVY · UNITHROID · Wegovy · XCOPRI · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for nurse practitioner - primary care in IL.

Looking for a nurse practitioner - primary care in Glen Ellyn?
Compare nurse practitioner - primary cares in the Glen Ellyn area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - primary cares nearby

Geographic Context

Nurse practitioner - primary cares within 10 mi
179
Per 100K population
19.3
County median income
$110,502
Nearest hospital
UCHICAGO MEDICINE ADVENTHEALTH GLENOAKS
3.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Maynard is a clinical cardiology specialist, with above-average Medicare volume (top 3% in IL), with low-engagement industry engagement in the top 5% of IL peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Maynard experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Maynard performed 1,680 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maynard receive payments from pharmaceutical companies?
Yes. Dr. Maynard received a total of $6,755 from 27 companies across 373 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maynard's costs compare to other nurse practitioner - primary cares in Glen Ellyn?
Dr. Maynard's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maynard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →